Following a full submission:
budesonide gastro-resistant capsule (Budenofalk®) is accepted for use within NHS Scotland.
Indication under review: symptomatic relief of chronic diarrhoea due to collagenous colitis.
budesonide (Budenofalk®) provides symptomatic improvement of diarrhoea associated with collagenous colitis compared with placebo.
|Drug Name:||budesonide (Budenofalk)|
|SMC Drug ID:||828/12|
|Manufacturer:||Dr Falk Pharma UK|
|Indication:||For the symptomatic relief of chronic diarrhoea due to collagenous colitis.|
|Sub Category:||1.5 Chronic bowel disorders|
|Submission Type:||Full submission|
|Date Advice Published:||14 January 2013|